FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:334-339 January 31, 2002 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations.

A 53-year-old woman reports severe watery diarrhea with cramps. She is in her 7th day of a 10-day course of cefixime, prescribed for bronchitis. How should she be evaluated and treated?

The Clinical Problem

Antibiotic-associated diarrhea is defined as otherwise unexplained diarrhea that occurs in association with the administration of antibiotics. The frequency of this complication varies among antibacterial agents. Diarrhea occurs in approximately 5 . . . [Full Text of this Article]

Strategies and Evidence

Mechanisms Other Than C. difficile Infection

Diarrhea Associated with C. difficile Infection

            Risk Factors

            Diagnostic Tests

            Treatment

            Relapsing Infection

            Epidemics

Areas of Uncertainty

Guidelines

Conclusions and Recommendations

Source Information

From the Department of Medicine, Johns Hopkins School of Medicine, Baltimore.

Address reprint requests to Dr. Bartlett at the Department of Medicine, Johns Hopkins University School of Medicine, 1830 E. Monument St., Rm. 439, Baltimore, MD 21287-0003, or at jb@jhmi.edu.

References

Related Letters:

Antibiotic-Associated Diarrhea
Periman P., Bartlett J. G.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:145, Jul 11, 2002. Correspondence

This article has been cited by other articles:

• Sloan, L. M., Duresko, B. J., Gustafson, D. R., Rosenblatt, J. E. (2008). Comparison of Real-Time PCR for Detection of the tcdC Gene with Four Toxin Immunoassays and Culture in Diagnosis of Clostridium difficile Infection. J. Clin. Microbiol. 46: 1996-2001 [Abstract] [Full Text]  
• Indra, A., Schmid, D., Huhulescu, S., Hell, M., Gattringer, R., Hasenberger, P., Fiedler, A., Wewalka, G., Allerberger, F. (2008). Characterization of clinical Clostridium difficile isolates by PCR ribotyping and detection of toxin genes in Austria, 2006-2007. J Med Microbiol 57: 702-708 [Abstract] [Full Text]  
• Monaghan, T, Boswell, T, Mahida, Y R (2008). Recent advances in Clostridium difficile-associated disease. Gut 57: 850-860 [Abstract] [Full Text]  
• Mehlhorn, A. J, Brown, D. A (2007). Safety Concerns with Fluoroquinolones. The Annals of Pharmacotherapy 41: 1859-1866 [Abstract] [Full Text]  
• Emerson, C. R. (2007). Clostridium difficile Associated Diarrhea, an Emerging Epidemic: Therapeutic Options. Journal of Pharmacy Practice 20: 347-353 [Abstract]  
• Musher, D. M., Manhas, A., Jain, P., Nuila, F., Waqar, A., Logan, N., Marino, B., Graviss, E. A. (2007). Detection of Clostridium difficile Toxin: Comparison of Enzyme Immunoassay Results with Results Obtained by Cytotoxicity Assay. J. Clin. Microbiol. 45: 2737-2739 [Abstract] [Full Text]  
• Padmanabhan, A., Stern, M., Wishin, J., Mangino, M., Richey, K., DeSane, M., on behalf of the Flexi-Seal Clinical Trial Investi, (2007). Clinical Evaluation of a Flexible Fecal Incontinence Management System. Am J Crit Care 16: 384-393 [Abstract] [Full Text]  
• Numan, S. C, Veldkamp, P., Kuijper, E. J, van den Berg, R. J, van Dissel, J. T (2007). Clostridium difficile-associated diarrhoea: bovine anti-Clostridium difficile whey protein to help aid the prevention of relapses. Gut 56: 888-889 [Full Text]  
• Crabtree, T., Aitchison, D., Meyers, B. F., Tymkew, H., Smith, J. R., Guthrie, T. J., Munfakh, N., Moon, M. R., Pasque, M. K., Lawton, J., Moazami, N., Damiano, R. J. Jr (2007). Clostridium Difficile in Cardiac Surgery: Risk Factors and Impact on Postoperative Outcome. Ann. Thorac. Surg. 83: 1396-1402 [Abstract] [Full Text]  
• Jank, T., Giesemann, T., Aktories, K. (2007). Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology 17: 15R-22R [Abstract] [Full Text]  
• Kazakova, S. V., Ware, K., Baughman, B., Bilukha, O., Paradis, A., Sears, S., Thompson, A., Jensen, B., Wiggs, L., Bessette, J., Martin, J., Clukey, J., Gensheimer, K., Killgore, G., McDonald, L. C. (2006). A Hospital Outbreak of Diarrhea Due to an Emerging Epidemic Strain of Clostridium difficile. Arch Intern Med 166: 2518-2524 [Abstract] [Full Text]  
• Hogenauer, C., Langner, C., Beubler, E., Lippe, I. T., Schicho, R., Gorkiewicz, G., Krause, R., Gerstgrasser, N., Krejs, G. J., Hinterleitner, T. A. (2006). Klebsiella oxytoca as a Causative Organism of Antibiotic-Associated Hemorrhagic Colitis. NEJM 355: 2418-2426 [Abstract] [Full Text]  
• Bartlett, J. G. (2006). Narrative Review: The New Epidemic of Clostridium difficile-Associated Enteric Disease.. ANN INTERN MED 145: 758-764 [Abstract] [Full Text]  
• Babcock, G. J., Broering, T. J., Hernandez, H. J., Mandell, R. B., Donahue, K., Boatright, N., Stack, A. M., Lowy, I., Graziano, R., Molrine, D., Ambrosino, D. M., Thomas, W. D. Jr. (2006). Human Monoclonal Antibodies Directed against Toxins A and B Prevent Clostridium difficile-Induced Mortality in Hamsters. Infect. Immun. 74: 6339-6347 [Abstract] [Full Text]  
• Noren, T., Wullt, M., Akerlund, T., Back, E., Odenholt, I., Burman, L. G. (2006). Frequent Emergence of Resistance in Clostridium difficile during Treatment of C. difficile-Associated Diarrhea with Fusidic Acid.. Antimicrob. Agents Chemother. 50: 3028-3032 [Abstract] [Full Text]  
• Roy, C. C., Kien, C. L., Bouthillier, L., Levy, E. (2006). Short-Chain Fatty Acids: Ready for Prime Time?. Nutr Clin Pract 21: 351-366 [Abstract] [Full Text]  
• Cabana, M. D., Shane, A. L., Chao, C., Oliva-Hemker, M. (2006). Probiotics in Primary Care Pediatrics. CLIN PEDIATR 45: 405-410 [Abstract]  
• Garey, K. W, Graham, G., Gerard, L., Dao, T., Jiang, Z. D., Price, M., DuPont, H. L (2006). Prevalence of Diarrhea at a University Hospital and Association with Modifiable Risk Factors. The Annals of Pharmacotherapy 40: 1030-1034 [Abstract] [Full Text]  
• Cavalcante, I. C., Castro, M. V., Barreto, A. R. F., Sullivan, G. W., Vale, M., Almeida, P. R. C., Linden, J., Rieger, J. M., Cunha, F. Q., Guerrant, R. L., Ribeiro, R. A., Brito, G. A. C. (2006). Effect of Novel A2A Adenosine Receptor Agonist ATL 313 on Clostridium difficile Toxin A-Induced Murine Ileal Enteritis.. Infect. Immun. 74: 2606-2612 [Abstract] [Full Text]  
• Ticehurst, J. R., Aird, D. Z., Dam, L. M., Borek, A. P., Hargrove, J. T., Carroll, K. C. (2006). Effective Detection of Toxigenic Clostridium difficile by a Two-Step Algorithm Including Tests for Antigen and Cytotoxin.. J. Clin. Microbiol. 44: 1145-1149 [Abstract] [Full Text]  
• Carneiro, B. A., Fujii, J., Brito, G. A. C., Alcantara, C., Oria, R. B., Lima, A. A. M., Obrig, T., Guerrant, R. L. (2006). Caspase and Bid Involvement in Clostridium difficile Toxin A-Induced Apoptosis and Modulation of Toxin A Effects by Glutamine and Alanyl-Glutamine In Vivo and In Vitro. Infect. Immun. 74: 81-87 [Abstract] [Full Text]  
• McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C. Jr., Kazakova, S. V., Sambol, S. P., Johnson, S., Gerding, D. N. (2005). An Epidemic, Toxin Gene-Variant Strain of Clostridium difficile. NEJM 353: 2433-2441 [Abstract] [Full Text]  
• Borek, A. P., Aird, D. Z., Carroll, K. C. (2005). Frequency of Sample Submission for Optimal Utilization of the Cell Culture Cytotoxicity Assay for Detection of Clostridium difficile Toxin. J. Clin. Microbiol. 43: 2994-2995 [Abstract] [Full Text]  
• Pelaez, T., Alcala, L., Alonso, R., Martin-Lopez, A., Garcia-Arias, V., Marin, M., Bouza, E. (2005). In Vitro Activity of Ramoplanin against Clostridium difficile, Including Strains with Reduced Susceptibility to Vancomycin or with Resistance to Metronidazole. Antimicrob. Agents Chemother. 49: 1157-1159 [Abstract] [Full Text]  
• Tanaka, J., Fukuda, Y., Shintani, S., Hori, K., Tomita, T., Ohkusa, T., Matsumoto, T., Miwa, H. (2005). Influence of antimicrobial treatment for Helicobacter pylori infection on the intestinal microflora in Japanese macaques. J Med Microbiol 54: 309-314 [Abstract] [Full Text]  
• Barbut, F., Decre, D., Lalande, V., Burghoffer, B., Noussair, L., Gigandon, A., Espinasse, F., Raskine, L., Robert, J., Mangeol, A., Branger, C., Petit, J.-C. (2005). Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 54: 181-185 [Abstract] [Full Text]  
• Delmee, M., Van Broeck, J., Simon, A., Janssens, M., Avesani, V. (2005). Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J Med Microbiol 54: 187-191 [Abstract] [Full Text]  
• Musher, D. M., Musher, B. L. (2004). Contagious Acute Gastrointestinal Infections. NEJM 351: 2417-2427 [Full Text]  
• Pepin, J., Valiquette, L., Alary, M.-E., Villemure, P., Pelletier, A., Forget, K., Pepin, K., Chouinard, D. (2004). Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171: 466-472 [Abstract] [Full Text]  
• Noren, T., Akerlund, T., Back, E., Sjoberg, L., Persson, I., Alriksson, I., Burman, L. G. (2004). Molecular Epidemiology of Hospital-Associated and Community-Acquired Clostridium difficile Infection in a Swedish County. J. Clin. Microbiol. 42: 3635-3643 [Abstract] [Full Text]  
• Dial, S., Alrasadi, K., Manoukian, C., Huang, A., Menzies, D. (2004). Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 171: 33-38 [Abstract] [Full Text]  
• Goncalves, C., Decre, D., Barbut, F., Burghoffer, B., Petit, J.-C. (2004). Prevalence and Characterization of a Binary Toxin (Actin-Specific ADP-Ribosyltransferase) from Clostridium difficile. J. Clin. Microbiol. 42: 1933-1939 [Abstract] [Full Text]  
• Young, V. B., Schmidt, T. M. (2004). Antibiotic-Associated Diarrhea Accompanied by Large-Scale Alterations in the Composition of the Fecal Microbiota. J. Clin. Microbiol. 42: 1203-1206 [Abstract] [Full Text]  
• Thielman, N. M., Guerrant, R. L. (2004). Acute Infectious Diarrhea. NEJM 350: 38-47 [Full Text]  
• Reid, G., Jass, J., Sebulsky, M. T., McCormick, J. K. (2003). Potential Uses of Probiotics in Clinical Practice. Clin. Microbiol. Rev. 16: 658-672 [Abstract] [Full Text]  
• Cremieux, A.-C., Muller-Serieys, C., Panhard, X., Delatour, F., Tchimichkian, M., Mentre, F., Andremont, A. (2003). Emergence of Resistance in Normal Human Aerobic Commensal Flora during Telithromycin and Amoxicillin-Clavulanic Acid Treatments. Antimicrob. Agents Chemother. 47: 2030-2035 [Abstract] [Full Text]  
• Hecker, M. T., Aron, D. C., Patel, N. P., Lehmann, M. K., Donskey, C. J. (2003). Unnecessary Use of Antimicrobials in Hospitalized Patients: Current Patterns of Misuse With an Emphasis on the Antianaerobic Spectrum of Activity. Arch Intern Med 163: 972-978 [Abstract] [Full Text]  
• Aboudola, S., Kotloff, K. L., Kyne, L., Warny, M., Kelly, E. C., Sougioultzis, S., Giannasca, P. J., Monath, T. P., Kelly, C. P. (2003). Clostridium difficile Vaccine and Serum Immunoglobulin G Antibody Response to Toxin A. Infect. Immun. 71: 1608-1610 [Abstract] [Full Text]  
• Periman, P., Bartlett, J. G. (2002). Antibiotic-Associated Diarrhea. NEJM 347: 145-145 [Full Text]  
• Barbut, F., Meynard, J. L. (2002). Managing antibiotic associated diarrhoea. BMJ 324: 1345-1346 [Full Text]